Ray Dalio (Bridgewater Associates) trim Regeneron Pharmaceuticals Inc
Ray Dalio (Bridgewater Associates) trim $5.6M of disclosed value in Regeneron Pharmaceuticals Inc.
Signal
Investor Move
Action
Trim
Capital
$5.6M disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.